Davis Blaine
- SEC CIK
- 0001802188
In the past year, 1 open-market sale filing worth $72.2K and no purchases.
Current role at each company
- RNAC Cartesian Therapeutics, Inc.Chief Financial Officeras of Jan 8, 2026
- TARA Protara Therapeutics, Inc.Chief Financial Officeras of Jul 19, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $72.2K
- 1 filing
- Net
- −$72.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Davis Blaine as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RNAC Cartesian Therapeutics, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 (view filing) | Jan 6 | 2 days | Davis BlaineChief Financial Officer | SSale | −10.6K | $6.82 | −$72.2K | −8.0%121.2K after | |
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Davis BlaineChief Financial Officer | SSale | −7.99K | $16.78 | −$134.0K | −7.8%94.8K after | 2 lots |